Pharma manufacturing is shifting gears towards greater efficiency and innovation. In line with this shift, BENEO offers galenIQ™ – an extraordinary granulation binder. This product will be showcased by BENEO at CPHI Europe 2025. Visit Stand 8.0L70 at Messe Frankfurt to discover how galenIQ™ meets the growing demand for continuous manufacturing solutions in pharmaceuticals.
As continuous manufacturing becomes increasingly prominent in the pharma industry, galenIQ™ offers a compelling binder solution. Its unique performance profile includes fast preparation, robust granule formation, excellent flowability, and rapid dissolution – key factors for success in twin screw and high-shear granulation.
Designed to meet the dual requirements of efficient manufacturing and enhanced patient compliance, galenIQ™ granulation binder combines technical performance with sensory appeal. Thanks to its pleasant, sweet taste and plant-based origin, it supports the development of more palatable and patient-friendly dosage forms. Produced from beet sugar, BENEO’s filler-binder is non-synthetic and peroxide-free. In addition to aligning with modern consumer needs, it also provides formulators with a stable, consistent, and reliable excipient solution.
Proven performance in modern granulation
In recent internal trials, galenIQ™ delivered impressive results across key metrics for twin screw granulation (TSG). It showed excellent compactability and produced high-strength tablets (>1.8 MPa) while maintaining rapid disintegration – a desired combination in continuous manufacturing. These attributes make galenIQ™ a particularly strong performer for TSG lines when stability, throughput, and formulation flexibility are essential.
“galenIQ™ sets a new benchmark in excipient functionality. Unlike traditional binders, the isomalt-based excipient showed lower sensitivity to concentration levels. Formulators benefit from greater process control and more consistent product quality. This combination of reliability and performance makes galenIQ™ a strong choice for manufacturers seeking both efficiency in production and confidence in regulatory compliance,” says Dr Maj-Britt Cepok, Head of Pharma at BENEO.
Discover galenIQ™ at CPHI Europe
Meet the BENEO team at CPHI Europe 2025!
Event details
- Dates: 28 to 30 October
- Venue: Messe Frankfurt, Germany
- Stand Number: 8.0L70
Things to look forward to:
- Breakthrough Research Finding: Get insights into galenIQ™’s compatibility with TSG technologies.
- Live Application Samples: Experience its role in better tablets and syrups.
- Expert Consultations: Talk with seasoned pharmaceutical experts about tailoring excipients for unique challenges.
Savannah Fine Chemicals is the South African agent for BENEO and distributor of galenIQ™.
Leave a Reply
You must be logged in to post a comment. Need an account? Register here.